This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

APO-Norflox 400 mg (2015-08-25)

Starting date:
August 25, 2015
Posting date:
August 31, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-54836

Affected Products

APO-Norflox 400 mg

Reason

Levels of excipients crospovidone and magnesium stereate do not meet the quantities specified in the regulatory filing.

Depth of distribution

Wholesalers, Distributors, and Retailers

Affected products

APO-Norflox 400 mg

DIN, NPN, DIN-HIM
DIN 02229524
Dosage form

Tablet

Strength

Norfloxacin 400 mg

Lot or serial number

MC8181

Companies
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA